Emergent Biosolutions, Inc. Securities Litigation
On June 8, 2018 the Honorable Roger W. Titus certified a class of investors who purchased or otherwise acquired Emergent Biosolutions, Inc. common stock.
July 24, 2018
Aeterna Zentaris, Inc. Securities Litigation
On February 28, 2018 the Honorable Peter Sheridan of the United States District Court for the District of New Jersey certified a class of investors ...
March 19, 2018
LeapFrog Enterprises Inc. Securities Litigation
On February 26, 2018, parties in the LeapFrog Enterprises Inc. securities litigation reached an agreement to settle the case.
March 5, 2018
What A Solar Eclipse Has To Do With Market Efficiency
By Daniel Bettencourt and Steven Feinstein (Law360 November 17, 2017, 11:28 AM EST) To read the full article, please click here or read below. On Nov. ...
November 17, 2017
Marvell Technology Group, Ltd. Securities Litigation
The United States District Court for the Northern District of California certified a class of investors who purchased or otherwise acquired Marvell Technology Group, Ltd. ...
November 14, 2017
Silver Wheaton Corp. Securities Litigation
On May 13, 2017 the United States District Court for the Central District of California certified a class of investors who purchased or otherwise acquired ...
May 15, 2017
STAAR Surgical Company Securities Litigation
The United States District Court for the Central District of California certified a class of investors who purchased or otherwise acquired STAAR common stock.
January 6, 2017
RESTRUCTURING ELECTRICITY MARKETS
By Andrew N. Kleit, Ph.D. Crowninshield Financial Research* To read the full article, please click here or read below. As the director of the Penn State Electricity ...
November 14, 2016
Urban Outfitters, Inc. Securities Litigation
On 21 December 2015, parties in the Urban Outfitters, Inc. securities litigation reached an agreement to settle the case. CFR provided analysis of market efficiency in ...
June 10, 2016
Intercept Pharmaceuticals Inc. Securities Litigation
On 6 May 2016, parties in the Intercept Pharmaceuticals Inc. securities litigation reached an agreement to settle the case. CFR provided analysis of market efficiency ...
May 12, 2016